USA flag logo/image

An Official Website of the United States Government

MICROENCAPSULATED ANTIBIOTICS AND VITAMINS FOR LARVAL SHRIMP

Award Information

Agency:
Department of Agriculture
Branch:
N/A
Award ID:
14776
Program Year/Program:
1991 / SBIR
Agency Tracking Number:
14776
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Rangen, Inc.
P.O. Box 706, 115 13th Ave. S. Buhl, ID 83316
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1991
Title: MICROENCAPSULATED ANTIBIOTICS AND VITAMINS FOR LARVAL SHRIMP
Agency: USDA
Contract: N/A
Award Amount: $36,720.00
 

Abstract:

TREATMENT OF DISEASED FINFISH AND SHRIMP LARVAE IS LIMITED TO CONTACT EXPOSURE WITH CHEMICALS ADMINISTERED IN THE WATER. HOWEVER, LARVAE REQUIRE INGESTION OF APPROPRIATE ANTIBIOTICS FOR FAST, EFFECTIVE RECOVERY FROM SYSTEMIC BACTERIAL INFECTIONS. THE AQUACULTURE INDUSTRY LACKS A MEDICATED PRODUCT DEVELOPED FOR LARVAL ANIMALS. MICROENCAPSULATION IS CURRENTLY BEING TESTED AS A DELIVERY SYSTEM OF LIVE FOOD REPLACEMENTS FOR AQUATIC LARVAL SPECIES. WE PROPOSE TO ENCAPSULATE ANTIBIOTICS AND VITAMIN SUPPLEMENTS WITHIN MICROCAPSULES SUBSEQUENTLY INCORPORATED INTO LIPID-ENRICHED MICROPARTICLES. MICROCAPSULES WILL BE PRODUCED BY A PROCESS THAT WILL PROTECT THE LOW MOLECULAR WEIGHT, WATER-SOLUBLE ANTIBIOTICS AND VITAMINS UNTIL INGESTION BY PENAEID SHRIMP LARVAE. IN-VITRO ANTIBIOTIC LEACHING RATES WILL BE CORRELATED WITH SURVIVAL OF "MEDICATED" LARVAE AGAINST VIBRIO SP. CHALLENGE TO DETERMINEFEASIBILITY FOR PHASE-II R&D. RESULTS OF IN-VITRO TESTS ANDWHOLE ANIMAL RESPONSES TO TEST MEDICATIONS, INCLUDING A CHALLENGE WITH LIVE BACTERIA, WILL DETERMINE COMMERCIALIZATION POTENTIAL.

Principal Investigator:

Blake F Grant
0

Business Contact:

Small Business Information at Submission:

Rangen Aquaculture Resch Cente
Rt 1 Box 264 Hagerman, ID 83332

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No